Thakku SG, Lirette J, Murugesan K, et al. Genome-wide tiled detection of circulating Mycobacterium tuberculosis cell-free DNA using Cas13. Nature communications. 2023;14(1):1803. doi:10.1038/s41467-023-37183-8
Publications
Diaz-Cuadros M, Miettinen TP, Skinner OS, et al. Author Correction: Metabolic regulation of species-specific developmental rates. Nature. 2023;616(7956):E4. doi:10.1038/s41586-023-05924-w
Elomaa H, Ahtiainen M, Väyrynen SA, et al. Spatially resolved multimarker evaluation of CD274 (PD-L1)/PDCD1 (PD-1) immune checkpoint expression and macrophage polarisation in colorectal cancer. British journal of cancer. 2023. doi:10.1038/s41416-023-02238-6
Sharma R, Singh S, Whiting ZM, Molitor M, Vernall AJ, Grimsey NL. Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias. International journal of molecular sciences. 2023;24(7). doi:10.3390/ijms24076406
Zekavat SM, Viana-Huete V, Matesanz N, et al. mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease. Nature cardiovascular research. 2023;2:144-158. doi:10.1038/s44161-022-00206-6
Shi L, Shen W, Davis MI, et al. SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers. Nature cancer. 2023;4(3):365-381. doi:10.1038/s43018-023-00523-0
Toker J, Iorgulescu B, Ling AL, et al. Clinical importance of the lncRNA NEAT1 in cancer patients treated with immune checkpoint inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023. doi:10.1158/1078-0432.CCR-22-3714
Sheu YH, Sun J, Lee H, et al. An efficient landmark model for prediction of suicide attempts in multiple clinical settings. Psychiatry research. 2023;323:115175. doi:10.1016/j.psychres.2023.115175
Martinecz A, Boeree MJ, Diacon AH, et al. High rifampicin peak plasma concentrations accelerate the slow phase of bacterial decline in tuberculosis patients: Evidence for heteroresistance. PLoS computational biology. 2023;19(4):e1011000. doi:10.1371/journal.pcbi.1011000
Schneider AC, Chandrasekar T, Bowler N, et al. Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate Cancer. The Journal of urology. 2023;209(6):1112-1119. doi:10.1097/JU.0000000000003396